Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Biomea Fusion, Inc. (BMEA)

11.11   0.51 (4.81%) 08-19 02:04
Open: 10.6 Pre. Close: 10.6
High: 11.36 Low: 10.5504
Volume: 123,826 Market Cap: 325(M)
Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in oncogenic signaling in multiple cancers. The company was incorporated in 2017 and is headquartered in Redwood City, California.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 13.82 - 13.89 13.89 - 13.94
Low: 9.69 - 9.74 9.74 - 9.79
Close: 10.51 - 10.61 10.61 - 10.68

Technical analysis

as of: 2022-08-18 3:51:13 PM
Overall:       
Stoxline posted a STRONG SELL today, same as yesterday. Downward movement continues.
Target: Six months: 14.61     One year: 16.56
Support: Support1: 9.81    Support2: 8.16
Resistance: Resistance1: 12.51    Resistance2: 14.18
Pivot: 11.48
Moving Average: MA(5): 11.91     MA(20): 11.4
MA(100): 7.82     MA(250): 8.62
MACD: MACD(12,26): 0.2     Signal(9): 0.3
Stochastic oscillator: %K(14,3): 44.6     %D(3): 62
RSI: RSI(14): 48.9
52-week: High: 14.85  Low: 2.83
Average Vol(K): 3-Month: 217 (K)  10-Days: 230 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ BMEA ] has closed above bottom band by 39.3%. Bollinger Bands are 11.5% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Thu, 18 Aug 2022
This Healthcare Stock Dipped Over 30%; Here Are 83 Biggest Movers From Yesterday By Benzinga - Investing.com UK

Wed, 17 Aug 2022
Healthcare Stocks Moving Wednesday: BWV, EAR, SAVA, BIVI, PAVM, UBX, BMEA, OMIC - InvestorsObserver

Sun, 14 Aug 2022
Short Interest in Biomea Fusion, Inc. (NASDAQ:BMEA) Drops By 17.2% - MarketBeat

Fri, 12 Aug 2022
We Think Biomea Fusion (NASDAQ:BMEA) Can Afford To Drive Business Growth - Nasdaq

Sat, 06 Aug 2022
Biomea Fusion, Inc. (NASDAQ:BMEA) Expected to Earn Q3 2022 Earnings of ($0.64) Per Share - Defense World

Fri, 29 Jul 2022
Short Interest in Biomea Fusion, Inc. (NASDAQ:BMEA) Decreases By 78.2% - Defense World

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. 29 (M)
Shares Float 20 (M)
% Held by Insiders 34.7 (%)
% Held by Institutions 63.8 (%)
Shares Short 545 (K)
Shares Short P.Month 2,860 (K)

Stock Financials

EPS -1.86
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 5.13
Profit Margin (%) 0
Operating Margin (%) 0
Return on Assets (ttm) -20.7
Return on Equity (ttm) -34.6
Qtrly Rev. Growth 0
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) -2.08
Qtrly Earnings Growth 0
Operating Cash Flow -50 (M)
Levered Free Cash Flow -30 (M)

Stock Valuations

PE Ratio -6.03
PEG Ratio 0
Price to Book value 2.16
Price to Sales 0
Price to Cash Flow -6.5

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
StockChart iOS
stoxline_lite
StoxlineLite iOS
stoxline_pro
StoxlineLite iOS
Option_Calculator
OptionCalc iOS
android_stock_chart
StockChart Android
stoxline_lite
StoxlineLite Android
stoxline_pro
StoxlinePro Android
Option_Calculator
OptionCalc Android
(c) 2006-2022 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.